Key facts
- Notable investors include Benzai10 Investment Fund, Innovation and Entrepreneurship Federation of CCS NIAM.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Biome Technologies (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Biome Technologies (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biome Technologies (Biotechnology)
Operator of a biotechnology-focused contract research organization designed to provide scientific, regulatory, and IP-driven development services. The company offers research and development support, bioanalysis, field trials, regulatory guidance, industrial biotechnology services, technology transfer, and training programs, enabling biotechnology, agriculture, bioenergy, and food industry clients to develop innovative products, meet regulatory standards, and accelerate commercialization.
- Sector
- Healthcare
- HQ
- Ahmadnagar, India
- Founded
- 2021
- Employees
- 20
- Website
- inventbiome.com/
- Ownership
- Privately Held (backing)
Biome Technologies (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biome Technologies (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biome Technologies (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.